Azelastine market was valued at USD 404 million in 2024 and is projected to reach USD 492 million by 2031, exhibiting a CAGR of 2.9% during the forecast period.
Global vaccine adjuvants market, valued at USD 623 million in 2024, is projected to reach USD 1,152 million by 2031, registering a 9.4% CAGR during 2025–2031.
Medical Radiographic Equipment Market is projected to expand to USD 20.22 billion by 2031, registering a 6.4% CAGR during the forecast period of 2025–2032.
The global reverse transcriptase market, valued at USD 316 million in 2024, is projected to rise to USD 417 million by 2031, advancing at a CAGR of 4.1% over the forecast period
Chlorhexidine Gluconate API Market is poised for sustained growth, rising from USD 137 million in 2024 to USD 176 million by 2031, registering a 3.8% CAGR during the forecast period.
The global Human Neuregulin Molecule Market, valued at USD 202 million in 2024, is poised for consistent growth, expanding from USD 213 million in 2025 to USD 289 million by 2031, at a CAGR of 5.4%.
Autoimmune disease drugs market is poised for steady expansion, projected to grow from USD 134.92 billion in 2025 to USD 169.34 billion by 2031 at a 3.9% CAGR.
Non-Receptor Tyrosine Kinase Inhibitors (NRTKI) Market is projected to grow from USD 8.45 billion in 2025 to USD 15.02 billion by 2031, registering a strong CAGR of 9.6% during the forecast period.
Global Sugar Coated Tablets Market, is projected to reach USD 1,695 million by 2031, registering a CAGR of 1.6% during the forecast period (2025–2031).
Rifabutin market, valued at USD 284.7 million in 2024, is projected to grow to USD 433.8 million by 2032, registering a robust CAGR of 5.3% during the forecast period.
Market growth is driven by increasing demand in oil well logging and mineral analysis, particularly in shale gas exploration. However, stringent regulatory frameworks governing radioactive materials pose challenges to market expansion.
Global Multilayer IR Glazing market size was valued at USD 2.45 billion in 2024. The market is projected to grow from USD 2.68 billion in 2025 to USD 4.12 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.3% during the forecast period.
Global Contrast Injector Market is poised for steady growth, expanding from USD 503 million in 2025 to USD 636 million by 2031, registering a compound annual growth rate (CAGR) of 4.1% during the forecast period.
Market is projected to grow from USD 7.35 million in 2025 to USD 9.8 million by 2031, exhibiting a CAGR of 5.1% during the forecast period (2025–2032).
Global Aortic Stent System Market is projected to grow significantly from USD 1.87 billion in 2024 to USD 2.78 billion by 2031, registering a CAGR of 6.0% during the forecast period.